Abstract
Oxygen-derived free radicals are known to play a critical role in reperfusion injury, and antioxidants have been shown to protect against ischemia-reperfusion (I-R) injury. The study reported in this chapter was designed to examine the mechanism of propranolol protection, a nonspecific beta-adrenergic blocking drug, against acute I-R injury. Isolated rat hearts subjected to 60-minute global ischemia and 40-minute reperfusion showed a significant rise in the resting tension associated with a poor recovery of the contractile function. Hearts perfused with the buffer containing propranolol displayed almost complete recovery of contractile force and a significant decrease in resting tension. Antioxidant enzyme activities, superoxide dismutase (SOD), glutathione peroxidase (GSHPx), and catalase (CAT) were no different in control and propranolol-exposed hearts. Atenolol, a β1-specific blocker, offered no significant protection against I-R-induced contractile dysfunction. Perfusion with atenolol resulted in a decrease in catalase and an increase in GSHPx activities. Lipid peroxidation in the I-R hearts was significantly reduced by propranolol. It is suggested that propranolol protection under acute conditions may not involve β-blockade or changes in endogenous antioxidant enzymes. Rather, it may be secondary to the membrane-stabilizing and/or direct antioxidant effects of the drug. Protection by a chronic treatment has been earlier suggested to involve an increase in endogenous antioxidant reserve. Thus, propranolol protection, under acute as well as chronic treatments, appears to involve antioxidant effects with different characteristics.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Garlick PB, Radda GK, Seeley PJ. 1979. Studies on acidosis in the ischemic heart by phosphorus nuclear magnetic resonance. Biochem J 184:547–554.
Steenbergen RCS, Hill M, Jennings RB. 1989. Volume regulation and plasma membrane injury in aerobic, anaerobic and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity. Circ Res 57:864–875.
Bourdillon PDV, Poole-Wilson PA. 1981. The effects of ischemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium. Cardiovasc Res 15:121–130.
Weglicki M, Mak IT, Dickeas BF, Kramer JH. 1987. Models of injury of cardiovascular membranes by amphiphiles and free radicals. In Dhalla NS, Innes IR, Beamish RE(eds), Myocardial Ischemia. Boston: Martinus Nijhoff, pp. 113–122.
Ziegelhoffer A, Das PK, Sharma GP, Singal PK, Dhalla NS. 1979. Propranolol effects on myocardial ultrastructure and high energy phosphates in anesthetized dogs subjected to ischemia and reperfusion. Can J Physiol Pharmacol 57:979–986.
Edoute Y, Sanan D, Lochner A, Graney D, Kotez JCN. 1981. Effects of propranolol on myocardial ultrastructure, mitochondrial function and high energy phosphates of isolated working rat hearts with coronary artery ligation. J Mol Cell Cardiol 13:619–639.
Hearse DJ. 1979. Oxygen deprivation and early myocardial contractile failure: a reassessment of the possible role of adenosine triphosphate. Am J Cardiol 44:1115–1121.
Bolli R. 1991. Oxygen derived free radicals and myocardial reperfusion injury. An overview. Cardiovasc Drug Ther 5:249–268.
Ferrari R, Ceconi C, Curello S, Guarnieri C, Caldarera CM, Albertini A, Visioli O. 1985. Oxygen mediated myocardial damage during ischemia and reperfusion. Role of the cellular defenses against oxygen toxicity. J Mol Cell Cardiol 17:937–945.
Zweier JL, Flaherty JT, Weisfeldt ML. 1987. Direct measurement of free radical generation following reperhsion of ischemic myocardium. Proc Natl Acad Sci USA 84:1404–1407.
Dhaliwal M, Kirshenbaum LA, Randhawa AK, Singal PK. 1991. Correlation between antioxidant changes during hypoxia recovery on reoxygenation. Am J Physiol 261 (Heart Circ Physiol 30):H632–H638.
Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK. 1993. Free radicals and the heart. J Pharmacol Toxicol Methods 30:55–67.
Jolly SR, Kane WJ, Bailie MB, Abrams GD, Lucchesi BR. 1984. Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 54:277–285.
Mak IT, Weglicki WB. 1988. Protection by β-blocking agents against free-radical mediated sarcolemmal lipid peroxidation. Circ Res 63:262–266.
Nayler WG, Gordon M, Stephens DJ, Sturrock WG. 1985. The protective effect of prazosin on the ischemic and reperfused myocardium. J Mol Cell Cardiol 17:685–699.
Tamura Y, Chi L, Driscoll EM, Hoff PT, Freeman BA, Gallagher PK, Lucchesi BR. 1988. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart. Circ Res 63:944–959.
Nayler WG, Ferrari R, Williams A. 1980. Protective effect of pretreatment with verapamil, Nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol 46:242–248.
Mak IT, Kramer JH, Freedman AM, Tse SYH, Weglicki WB. 1990. Oxygen radical mediated injury of myocyte-protection by propranolol. J Mol Cell Cardiol 22:687–695.
Singal PK, Singh N, Seneviratne CK, Rigato C, Kowaluk B. 1995. Propranolol protection against ischemic injury: An antioxidant effect. J Mol Cell Cardiol A277:27.
Connally ME, Kersting F, Dollery CT. 1976. The clinical pharmacology of beta-adrenoreceptor-blocking drugs. Prog Cardiovasc Dis 19:203–234.
Slezak J, Tribulova N, Pristacova J, Uhrik B, Thomas T, Khaper N, Kaul N, Singal PK. 1995. Hydrogen peroxide changes in ischemic and reperfused heart: cytochemistry biochemical and X-ray microanalysis. Am J Pathol 147:772–781.
Marklund SL. 1985. Pyrogallol autooxidation. In Greenwald RN (ed), Handbook of Methods for Oxygen Radical Research. Boca Raton, FL: CRC Press, pp. 243–247.
Pagha DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169.
Claiborne A. 1985. Catalase activity. In Greenwald RA (ed), Handbook of Methods for Oxygen Radical Research. Boca Raton, FL: CRC Press, pp. 283–284.
Siveski-Iliskovic N, Kaul N, Singal PK. 1994. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 89:2829–2835.
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275.
Mak IT, Arroyo CM, Weglicki WB. 1989. Inhibition of sarcolemmal carbon-centred free radical formation by propranolol. Circ Res 65:1154–1156.
Sugawara H, Tobisi K, Onodera S. 1994. Absence of antioxidant effects of nifedipine and diltiazem on myocardial membrane lipid peroxidation in contrast with those of nisoldipine and propranolol. Biochem Pharmacol 47(5):887–892.
Nayler WG, Yepez CE, Fassold E, Ferrari R. 1978. Prolonged protective effect of propranolol on hypoxic heart muscle. Am J Cardiology 42:217–225.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Kluwer Academic Publishers
About this chapter
Cite this chapter
Kowaluk, B., Khaper, N., Rigatto, C., Palace, V., Singal, P.K. (1998). Mechanisms of Cardioprotective Effects of Propranolol Against Reperfusion Injury. In: Mochizuki, S., Takeda, N., Nagano, M., Dhalla, N.S. (eds) The Ischemic Heart. Progress in Experimental Cardiology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-39844-0_28
Download citation
DOI: https://doi.org/10.1007/978-0-585-39844-0_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-8105-1
Online ISBN: 978-0-585-39844-0
eBook Packages: Springer Book Archive